Study of association between effect of afatinib for EGFR-mutated non-small cell lung cancer and circulating free DNA detected with high sensitive analyses for EGFR mutation.
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000014091
- Lead Sponsor
- Makoto Maemondo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Interstitial pneumonitis or pulmonary fibrosis apparent on chest X-ray 2.Concomitant malignancies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method